Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Toomey

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Acta Neuropathologica|May 19, 2025
Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's diseaseClíona Farrell, Yazead Buhidma, Paige Mumford, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
LY191704 inhibits type I steroid 5 alpha-reductase in human scalpB L Neubauer, H M Gray, C W Hanke, et al.
The EMBO Journal|August 14, 2023
Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease modelsJavier Rueda-Carrasco, Dimitra Sokolova, Sang-Eun Lee, et al.
Nature Neuroscience|February 6, 2023
Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's diseaseSebastiaan De Schepper, Judy Z Ge, Gerard Crowley, et al.
The American Journal of Surgical Pathology|February 2, 2010
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphomaMatija Snuderl, Olga K Kolman, Yi-Bin Chen, et al.
EMBO Molecular Medicine|November 2, 2021
P-tau235: a novel biomarker for staging preclinical Alzheimer's diseaseJuan Lantero-Rodriguez, Anniina Snellman, Andrea L Benedet, et al.
Acta Neuropathologica Communications|September 8, 2022
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson'sChristina E Toomey, Wendy E Heywood, James R Evans, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 22, 2023
Artificial intelligence for dementia genetics and omicsConceicao Bettencourt, Nathan Skene, Sara Bandres-Ciga, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4Femke M Feringa, Sascha J Koppes-den Hertog, Lian Wang, et al.
Nature Metabolism|September 22, 2025
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseasesFemke M Feringa, Sascha J Koppes-den Hertog, Lian Y Wang, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Acta Neuropathologica|May 19, 2025
Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's diseaseClíona Farrell, Yazead Buhidma, Paige Mumford, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
LY191704 inhibits type I steroid 5 alpha-reductase in human scalpB L Neubauer, H M Gray, C W Hanke, et al.
The EMBO Journal|August 14, 2023
Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease modelsJavier Rueda-Carrasco, Dimitra Sokolova, Sang-Eun Lee, et al.
Nature Neuroscience|February 6, 2023
Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's diseaseSebastiaan De Schepper, Judy Z Ge, Gerard Crowley, et al.
The American Journal of Surgical Pathology|February 2, 2010
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphomaMatija Snuderl, Olga K Kolman, Yi-Bin Chen, et al.
EMBO Molecular Medicine|November 2, 2021
P-tau235: a novel biomarker for staging preclinical Alzheimer's diseaseJuan Lantero-Rodriguez, Anniina Snellman, Andrea L Benedet, et al.
Acta Neuropathologica Communications|September 8, 2022
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson'sChristina E Toomey, Wendy E Heywood, James R Evans, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 22, 2023
Artificial intelligence for dementia genetics and omicsConceicao Bettencourt, Nathan Skene, Sara Bandres-Ciga, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4Femke M Feringa, Sascha J Koppes-den Hertog, Lian Wang, et al.
Nature Metabolism|September 22, 2025
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseasesFemke M Feringa, Sascha J Koppes-den Hertog, Lian Y Wang, et al.
Pageof 10